Atria Investments LLC Amgen Inc Transaction History

Atria Investments LLC

$7.49 Billion
Q4 2024

A detailed history of Atria Investments LLC transactions in Amgen Inc stock. As of the latest transaction made, Atria Investments LLC holds 44,612 shares of AMGN stock, worth $13.1 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

44,612

Previous 47,047 5.18%

Holding current value

$13.1 Million

Previous $15.2 Million 23.3%

% of portfolio

0.16%

Previous 0.2%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$258.78 - $328.31 $630,129 - $799,434	-2,435 Reduced 5.18%	44,612 $11.6 Million
Q3 2024 Nov 01, 2024	SELL	$309.38 - $337.38 $827,591 - $902,491	-2,675 Reduced 5.38%	47,047 $15.2 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $559,657 - $680,130	2,130 Added 4.48%	49,722 $15.5 Million
Q1 2024 May 21, 2024	SELL	$268.87 - $324.56 $1.35 Million - $1.63 Million	-5,014 Reduced 9.53%	47,592 $13.5 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $364,372 - $411,055	1,425 Added 2.78%	52,606 $15.2 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $2.53 Million - $3.14 Million	11,565 Added 29.19%	51,181 $13.8 Million
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $539,317 - $637,732	2,517 Added 6.78%	39,616 $8.8 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $863,872 - $1.05 Million	-3,826 Reduced 9.35%	37,099 $8.97 Million
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $1.16 Million - $1.47 Million	-5,060 Reduced 11.0%	40,925 $10.7 Million
Q3 2022 Nov 01, 2022	BUY	$224.46 - $253.15 $1.63 Million - $1.84 Million	7,284 Added 18.82%	45,985 $10.4 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $62,522 - $69,576	-271 Reduced 0.7%	38,701 $9.42 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $554,314 - $613,216	2,528 Added 6.94%	38,972 $9.42 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $341,079 - $390,334	-1,715 Reduced 4.49%	36,444 $8.2 Million
Q3 2021 Nov 16, 2021	BUY	$212.27 - $248.7 $161,325 - $189,012	760 Added 2.03%	38,159 $8.11 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $537,701 - $596,540	2,302 Added 6.56%	37,399 $9.12 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $940,232 - $1.1 Million	-4,237 Reduced 10.77%	35,097 $8.73 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $145,623 - $173,411	673 Added 1.74%	39,334 $9.04 Million
Q3 2020 Nov 05, 2020	BUY	$234.65 - $260.95 $1.88 Million - $2.09 Million	8,006 Added 26.12%	38,661 $9.83 Million
Q2 2020 Sep 22, 2020	SELL	$197.81 - $242.74 $1.01 Million - $1.24 Million	-5,092 Reduced 14.24%	30,655 $7.23 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $45,924 - $60,908	252 Added 0.71%	35,747 $7.25 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $1.56 Million - $2 Million	8,234 Added 30.2%	35,495 $8.56 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $258,727 - $310,009	-1,486 Reduced 5.17%	27,261 $5.28 Million
Q2 2019 Aug 26, 2019	BUY	$166.7 - $195.41 $4.79 Million - $5.62 Million	28,747 New	28,747 $5.83 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $1.65 Million - $1.93 Million	-9,873 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $1.62 Million - $1.82 Million	-8,932 Reduced 47.5%	9,873 $484,000
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $81,885 - $95,586	459 Added 2.5%	18,805 $3.66 Million
Q3 2018 Oct 09, 2018	BUY	$185.29 - $208.89 $120,994 - $136,405	653 Added 3.69%	18,346 $3.8 Million
Q2 2018 Jul 13, 2018	SELL	$166.05 - $186.51 $320,808 - $360,337	-1,932 Reduced 9.84%	17,693 $3.27 Million
Q1 2018 Apr 30, 2018	BUY	$169.43 - $198.0 $338 - $396	2 Added 0.01%	19,625 $3.35 Million
Q4 2017 Jan 16, 2018	BUY	$168.79 - $188.59 $955,857 - $1.07 Million	5,663 Added 40.57%	19,623 $3.41 Million
Q3 2017 Oct 12, 2017	BUY	$167.29 - $191.0 $2.34 Million - $2.67 Million	13,960	13,960 $2.6 Million

Others Institutions Holding AMGN

# of Institutions

3,095

Shares Held

405M

Call Options Held

7.57M

Put Options Held

7.12M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Account

Atria Investments LLC Amgen Inc Transaction History